Jonathan Daniel Ip
-
Research
![Photo of [Clinical Infectious Diseases] Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong](https://fightcovid19.hku.hk/content/uploads/2020/04/cdc-w9KEokhajKw-unsplash1-390x220.jpg)
[Clinical Infectious Diseases] Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong
Clinical Infectious Diseases, 5 August 2020 Kelvin Kai-Wang To, Wan-Mui Chan, Jonathan Daniel Ip, Allen Wing-Ho Chu, Anthony Raymond Tam,…
Read More » -
Research
![Photo of [Journal of Clinical Virology] Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits](https://fightcovid19.hku.hk/content/uploads/2020/05/covid19_opening-390x220.jpg)
[Journal of Clinical Virology] Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits
Journal of Clinical Virology, 23 June 2020 Allen Wing-Ho Chu, Wan-Mui Chan, Jonathan Daniel Ip, Cyril Chik-Yan Yip, Jasper Fuk-Woo…
Read More » -
Research
![Photo of [Journal of Medical Virology] Identification of nsp1 gene as the target of SARS‐CoV‐2 real‐time RT‐PCR using nanopore whole genome sequencing](https://fightcovid19.hku.hk/content/uploads/2020/06/Screenshot-2020-06-11-at-12.26.49-PM-390x220.png)
[Journal of Medical Virology] Identification of nsp1 gene as the target of SARS‐CoV‐2 real‐time RT‐PCR using nanopore whole genome sequencing
Wan‐Mui Chan, Jonathan Daniel Ip, Allen Wing‐Ho Chu, Cyril Chik‐Yan Yip, Lap‐Sum Lo, Kwok‐Hung Chan, Anthony Chin‐Ki Ng, Rosana Wing‐Shan…
Read More » -
Research
![Photo of [The Lancet] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial](https://fightcovid19.hku.hk/content/uploads/2020/02/cover-yuen-kwok-yung-1024x538-1-390x220.png)
[The Lancet] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
The Lancet, May 8 2020 Ivan Fan-Ngai Hung,Kwok-Cheung Lung,Eugene Yuk-Keung Tso,Raymond Liu,Tom Wai-Hin Chung,Man-Yee Chu,Yuk-Yung Ng,Jenny Lo,Jacky Chan,Anthony Raymond Tam,Hoi-Ping…
Read More » -
Research
![Photo of [The Lancet Microbe] Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study](https://fightcovid19.hku.hk/content/uploads/2020/05/fusion-medical-animation-EAgGqOiDDMg-unsplash-390x220.jpg)
[The Lancet Microbe] Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study
The Lancet Microbe, 21 April 2020 Hin Chu, Jasper Fuk-Woo Chan, Terrence Tsz-Tai Yuen, Huiping Shuai, Shuofeng Yuan, Yixin Wang,…
Read More »